Literature DB >> 23722714

Modern antiplatelet management of coronary artery bypass patients: a role of platelet function testing in decision making.

Mate Petricevic1, Bojan Biocina, Ivica Safradin, Davor Milicic.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 23722714     DOI： 10.1007/s11239-013-0937-5

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN： 0929-5305            Impact factor:   2.300


× No keyword cloud information.
  6 in total

Review 1.  Assessment, mechanisms, and clinical implication of variability in platelet response to aspirin and clopidogrel therapy.

Authors:  Itsik Ben-Dor; Neal S Kleiman; Eli Lev
Journal:  Am J Cardiol       Date:  2009-05-13       Impact factor: 2.778

2.  Assessment of platelet function by whole blood impedance aggregometry in coronary artery bypass grafting patients on acetylsalicylic acid treatment may prompt a switch to dual antiplatelet therapy.

Authors:  Mate Petricevic; Bojan Biocina; Sanja Konosic; Tomislav Kopjar; Nino Kunac; Hrvoje Gasparovic
Journal:  Heart Vessels       Date:  2011-12-28       Impact factor: 2.037

3.  Relationship between postoperative clopidogrel use and subsequent angiographic and clinical outcomes following coronary artery bypass grafting.

Authors:  Judson B Williams; Renato D Lopes; Gail E Hafley; T Bruce Ferguson; Michael J Mack; C Michael Gibson; Robert A Harrington; Eric D Peterson; Peter K Smith; Rajendra H Mehta; John H Alexander
Journal:  J Thromb Thrombolysis       Date:  2013-11       Impact factor: 2.300

Review 4.  Aspirin in coronary artery bypass surgery: new aspects of and alternatives for an old antithrombotic agent.

Authors:  Norbert Zimmermann; Emmeran Gams; Thomas Hohlfeld
Journal:  Eur J Cardiothorac Surg       Date:  2008-04-29       Impact factor: 4.191

Review 5.  Antiplatelet therapy and coronary artery bypass graft surgery: perioperative safety and efficacy.

Authors:  Alexander Kulik; Vincent Chan; Marc Ruel
Journal:  Expert Opin Drug Saf       Date:  2009-03       Impact factor: 4.250

6.  Dual antiplatelet therapy in patients with aspirin resistance following coronary artery bypass grafting: study protocol for a randomized controlled trial [NCT01159639].

Authors:  Hrvoje Gasparovic; Mate Petricevic; Tomislav Kopjar; Zeljko Djuric; Lucija Svetina; Bojan Biocina
Journal:  Trials       Date:  2012-08-25       Impact factor: 2.279
  6 in total
  2 in total

1.  Impact of aspirin resistance on outcomes among patients following coronary artery bypass grafting: exploratory analysis from randomized controlled trial (NCT01159639).

Authors:  Mate Petricevic; Tomislav Kopjar; Hrvoje Gasparovic; Davor Milicic; Lucija Svetina; Boris Zdilar; Marko Boban; Martina Zrno Mihaljevic; Bojan Biocina
Journal:  J Thromb Thrombolysis       Date:  2015-05       Impact factor: 2.300

2.  The Utility of Platelet and Coagulation Testing of Antithrombotics: Fusing Science with Patient Care.

Authors:  Lisa K Jennings; Jayaprakash Kotha
Journal:  Drug Dev Res       Date:  2013-11-15       Impact factor: 4.360
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.